Search results
The rise and rise of Austin, America’s coolest city
The Telegraph via Yahoo News· 2 hours agoEddie Wilson is shaking his head in despair at the thought of Donald Trump becoming the next American president. “I’m too old to move out of the country,...
BILL’s (BILL) Buy Rating Reaffirmed at Needham & Company LLC
ETF DAILY NEWS· 5 hours agoNeedham & Company LLC restated their buy rating on shares of BILL (NYSE:BILL – Free Report) in a research report sent to investors on Friday, Benzinga reports. Citigroup boosted ...
Selvita completes acquisition of PozLab and significantly expands its drug development capabilities
WRBL Columbus· 42 minutes agoKRAKÓW, Poland, May 7, 2024 /PRNewswire/ -- Selvita S.A. [WSE: SLV] announced today completion of a strategic transaction in which it has acquired 100% of shares in PozLab. The closing of the ...
What’s Next for Culinary Cannabis After the DEA Moves to Reclassify
Food & Wine via Yahoo News· 10 hours agoSocial Tonics Jake Bullock cofounded Cann, a low-dose, THC-infused beverage company, with Luke...
‘Unacceptable!’ Majorca plans major tourist crackdown after pretty town overrun
Daily Express· 2 hours agoMeanwhile locals in Majorca are reportedly being “forced out of their homes” as the popular holiday...
Offshore driller to spend $15M in move to new Westchase HQ
Houston Chronicle· 16 hours agoOffshore drilling company Noble Corp. will spend $15 million to renovate its new headquarters in...
BBVA shares rise after Sabadell rejects takeover proposal
Reuters· 50 minutes ago, opens new tab rejected what it described as an unsolicited takeover proposal from BBVA. At 0805...
BioCryst Pharmaceuticals Inc (BCRX) Q1 2024 Earnings Call Transcript Highlights: Key Financial ...
GuruFocus.com via Yahoo Finance· 2 hours agoPositive Points ORLADEYO revenue in Q1 exceeded expectations, contributing significantly to the company's financial performance. BioCryst Pharmaceuticals Inc (NASDAQ:BCRX) ...
Q1 2024 BioCryst Pharmaceuticals Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 hours agoOver the next 12 months, ORLADEYO will be approaching the midway point of our global peak revenue goal. We'll be preparing to file for approval for ORLADEYO use in pediatric patients and we'll ...
FIVE at FIVE AU: RBA keeps cash rate on hold … for now
Proactive Investors· 3 hours agoTop-performing stocks in this index were Paladin Energy and AGL Energy (ASX:AGK), up 8.54% and 6.92%...